CORC

浏览/检索结果: 共9条,第1-9条 帮助

已选(0)清除 条数/页:   排序方式:
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/04
Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents 期刊论文
HEPATITIS MONTHLY, 2018, 卷号: 18, 期号: 6
作者:  Liu, Xu;  Gao, Yanhang;  Niu, Junqi
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 353-358
作者:  Wei L;  Wang G Q;  Sarah J;  Cheng Q;  Xie M R
收藏  |  浏览/下载:8/0  |  提交时间:2019/11/19
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
Journal of Gastroenterology and Hepatology, 2018, 卷号: Vol.33 No.6, 页码: 1168-1176
作者:  Wei, L;  Xie, Q;  Hou, JL;  Jia, JD;  Li, W
收藏  |  浏览/下载:5/0  |  提交时间:2019/02/25
Safety and Efficacy of Sofosbuvir-Based Direct-Acting Antiviral Agents in Kidney Transplant Recipients with HCV: A Systematic Review and Meta-Analysis. 期刊论文
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 卷号: Vol.18, 页码: 941
作者:  Wang, X;  Tan, P;  Xiang, T;  Qiu, Y;  Song, T
收藏  |  浏览/下载:2/0  |  提交时间:2019/02/28
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6, 页码: 1168-1176
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载:20/0  |  提交时间:2019/12/11
The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity 期刊论文
CURRENT PHARMACEUTICAL DESIGN, 2017, 卷号: 23, 期号: 30, 页码: 4493-4554
作者:  Wang, Shuni;  Wang, Yibing;  Wang, Jiang;  Sato, Tatsunori;  Izawa, Kunisuke
收藏  |  浏览/下载:37/0  |  提交时间:2019/01/08
Inhibition of hepatitis C virus infection by NS5A-specific aptamer 期刊论文
ANTIVIRAL RESEARCH, 2014, 卷号: 106, 页码: 116-124
作者:  Yu, Xiaoyan;  Gao, Yimin;  Xue, Binbin;  Wang, Xiaohong;  Yang, Darong
收藏  |  浏览/下载:13/0  |  提交时间:2019/04/09
Hepatitis B reactivation after interferon-based therapy versus pan-oral direct acting antiviral agents in chronic hepatitis C patients co-inf (CPCI-S收录) 会议
作者:  Wang, Cheng[1,2];  Li, Bing[3];  Chen, Jing[1];  Liu, Huiming[4];  Ji, Dong[3,5]
收藏  |  浏览/下载:6/0  |  提交时间:2019/04/11


©版权所有 ©2017 CSpace - Powered by CSpace